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OBJECTIVES: To determine if antibiotic prescribing in
community nursing homes (NHs) can be reduced by a mul-
ticomponent antibiotic stewardship intervention implemented
by medical providers and nursing staff and whether imple-
mentation is more effective if performed by a NH chain or a
medical provider group.
DESIGN: Two-year quality improvement pragmatic imple-
mentation trial with two arms (NH chain and medical pro-
vider group).
SETTING: A total of 27 community NHs in North Carolina
that are typical of NHs statewide, conducted before announce-
ment of the US Centers for Medicare and Medicaid Services
antibiotic stewardship mandate.
PARTICIPANTS: Nursing staff and medical care providers
in the participating NHs.
INTERVENTION: Standardized antibiotic stewardship qual-
ity improvement program, including training modules for
nurses andmedical providers, posters, algorithms, communica-
tion guidelines, quarterly information briefs, an annual quality
improvement report, an informational brochure for residents
and families, and free continuing education credit.
MEASUREMENTS: Antibiotic prescribing rates per 1000 res-
ident days overall and by infection type; rate of urine test
ordering; and incidence of Clostridium difficile and methicillin-
resistant Staphylococcus aureus (MRSA) infections.
RESULTS: Systemic antibiotic prescription rates decreased
from baseline by 18% at 12 months (incident rate ratio
[IRR] = 0.82; 95% confidence interval [CI] = 0.69-0.98) and
23% at 24 months (IRR = 0.77; 95% CI = 0.65-0.90). A
10% increase in the proportion of residents with the medical
director as primary physician was associated with a 4%
reduction in prescribing (IRR = 0.96; 95% CI = 0.92-0.99).
Incidence of C. difficile and MRSA infections, hospitaliza-
tions, and hospital readmissions did not change significantly.
No adverse events from antibiotic nonprescription were
reported. Estimated 2-year implementation costs per NH,
exclusive of medical provider time, ranged from $354
to $3653.
CONCLUSIONS: Antibiotic stewardship programs can be
successfully disseminated in community NHs through either
NH administration or medical provider groups and can
achieve significant reductions in antibiotic use for at least
2 years. Medical director involvement is an important ele-
ment of program success. J Am Geriatr Soc 68:46-54, 2020.
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Leaders in infectious diseases and public health have calledfor improved antibiotic stewardship programs that, by
promoting appropriate use of antimicrobials, will improve
patient outcomes and decrease the spread of infections caused
by multidrug-resistant organisms (MDROs).1-4 Stewardship
programs have been widely introduced in hospitals,5 with con-
siderable evidence of impact on prescribing rates and some evi-
dence of reduction in antibiotic-resistant infections.6-8
Nursing homes (NHs) are recognized as a key reservoir of
antibiotic resistance, in large measure due to the chronically ill
population, frequent antibiotic use, and the fact that they are
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increasingly being used for posthospitalizationmanagement.9-11
Furthermore, many antibiotic prescriptions in NHs are
thought to be unnecessary.12 To address this issue, the US
Centers for Medicare and Medicaid Services (CMS) recently
mandated that all NHs initiate antibiotic stewardship programs,
with the goal of reducing inappropriate overprescribing and,
ultimately, of slowing the development of resistant bacteria and
the occurrence of infections withMDROs.13
Sustainable antibiotic stewardship requires changes in
administrative policies and procedures.14 The NH industry
is a complex adaptive system, characterized by diverse, interre-
lated, yet independent, stakeholders.15,16 A potential barrier to
antibiotic stewardship dissemination is the industry’s fragmen-
tation into administrative units ranging from individual homes
to chains of up to 380 homes, with the majority of residents
cared for inmedium-sized, often regional, NH chains.17,18Med-
ical services are also fragmented, increasingly provided by long-
term care provider groups that serve multiple homes.19 Prior
studies have demonstrated that NH medication reduction can
be either nursing administration20 or physician led,21 and
suggested that medical practices specializing in long-term care
may more effectively implement quality improvement19,22;
however, it is not known whether and to what extent working
within one administrative system or the other is more likely
to effect system change and improve outcomes, and which
approach is more cost effective. Therefore, a major goal of our
research was to answer this question within the context of a dis-
semination research study. On the one hand, we hypothesized
that a nursing administration-led effort, introduced and
supported by the corporate nursing director, by virtue of hav-
ing the ability to change systems of education, communica-
tion, nursing practice, and documentation related to infection
management, might be more effective in promoting antibiotic
stewardship. On the other hand, we hypothesized that a med-
ical provider group might be more effective in promoting
antibiotic stewardship, by virtue of their prescribing ability
and influence in the NHs.
Building on an efficacy study that achieved a 24%
reduction in antibiotic prescribing with education, monitor-
ing, and feedback by a university-based research team,22 we
sought to determine whether similar reductions in prescrib-
ing could be implemented and sustained if responsibility for
education and monitoring was largely delegated to NH staff
or medical providers. We, therefore, recruited two groups
of NHs, a NH chain arm and a medical provider group
arm, to (a) estimate the overall change in total systemic
antibiotic prescribing rates and (b) evaluate differences by
study arm. As secondary aims, we sought to identify char-
acteristics related to changes in prescribing, to determine if
hospitalization and adverse event rates were affected, and
to estimate implementation costs.
METHODS
Sample
NHs were recruited into two study arms: a NH chain arm
and a medical provider arm. The NH chain was recruited in
consultation with staff of our state long-term care associa-
tion; the medical provider group was selected in consultation
with the Carolinas Society for Post-Acute and Long-Term
Care Medicine. The participating NH chain is for profit and
had 21 NHs in North Carolina. The NH medical provider
group had medical directorship in 20 North Carolina NHs
and employed 12 physicians, 13 nurse practitioners, and
6 physician assistants. Six NHs were ineligible because
they were in both arms; two additional NHs were ex-
cluded because they were participating in an unrelated
clinical trial; four declined to participate; and two became
ineligible because the medical provider group relinquished
medical directorship, yielding a final sample of 27 homes
(14 in the NH chain arm and 13 in the medical provider
group).
Intervention
The project’s multicomponent intervention provided the same
resources to both arms; however, the mode of delivery differed
by study arm. The entry point for information and training
within the NH arm was the corporate Vice President of Clini-
cal Services and nursing leadership; within the medical pro-
vider NHs, it was the medical director and other medical care
providers (physicians, nurse practitioners, and physician assis-
tants). The intervention was conducted actively for 18 months,
with 6 months of postintervention follow-up data collection.
Intervention components included: an optional stan-
dardized system for recording and reporting antibiotic pre-
scribing; two 1-hour in-service training modules for nurses;
two 1-hour case-discussion audiocasts on CD-ROM mailed
to all medical providers; posters for placement within NHs;
pocket information and reminder cards containing an algo-
rithm to guide staff in determining when to obtain/not
obtain urine cultures and guidelines for gathering clinical
information before contacting on-call medical providers;
pocket cards for medical providers containing common rea-
sons for antibiotic overprescribing and infection control
guidelines; periodic quality improvement reports to nurses
and medical directors demonstrating and comparing their
NH-specific rates with other (deidentified) NHs; an informa-
tional brochure for residents and families; and free internet
access to training modules and continuing education credit.
Table 1 summarizes the components of the study intervention;
examples of key components are included in Supplementary
Appendix S1. In addition, the entire 10-module nurse training
is available (including free continuing education credits for
nurses) at https://nursinghomeinfections.unc.edu/ by clicking
on “for nurses.” A feature of the intervention approach was a
focus on when not to prescribe antibiotics, in contrast to most
antibiotic stewardship interventions in the literature, which
have tended to focus on guidelines on when to prescribe.23
The study was conducted between May 1, 2015, and April
30, 2017, terminating 6 months before the CMS mandate for
antibiotic stewardship was announced.
Data Collection and Measures
Outcome measures were collected by participating NHs
and submitted monthly to the research office. Outcomes
related to antibiotic prescribing were measured at baseline
over a 4-month period, and at study months 9 to 12 and
21 to 24. The primary outcome was the rate of systemic
antibiotic prescriptions per 1000 resident-days. Secondary
outcomes included rates of antibiotic prescribing for pre-
sumed urinary tract, respiratory, skin/soft tissue, and other
infections; the rate of urine culture ordering (an activity
linked to overprescribing)24; the incidence of infections with
methicillin-resistant Staphylococcus aureus (MRSA) and
Clostridium difficile; and the rates of hospitalization and of
30-day rehospitalizations. Study staff periodically visited
participating NHs to verify data, review records, and con-
duct retraining in record-keeping procedures if preventionist
turnover had occurred.
Data regarding resident and NH characteristics were
collected from each NH administrator, to characterize the
sample. These included turnover rates of NH administra-
tors, directors of nursing, infection preventionist (nurses),
and medical directors. Study methods were approved by
the Institutional Review Board of the University of North
Carolina at Chapel Hill.
Sample Size and Data Analysis
Power estimates focused on a two-sided test for an outcome
difference between the two study arms (because no direc-
tionality was hypothesized), using a 3-month observation
period (which the study ultimately expanded to 4 months),
and controlling for clustering, modeling the degree of differ-
ence observed in our prior, smaller study and using assump-
tions about interclass correlation based on prior research.
Calculations demonstrated that sample size of 16 sites in a
single arm would have 80% power to detect a reduction in
antibiotic prescription rate within treatment arm of 14%
from the baseline rate of 1.53 per 100 resident days.
Preliminary analyses computed means, proportions,
and frequencies to characterize the NHs and residents and
identify differences between the two study arms. Changes in
year 1 and year 2 outcomes relative to baseline were com-
pared across the study arms using Wilcoxon rank-sum tests.
Testing was also performed without distinction of study
arm, as no evidence was found for statistically significant
differences between study arms. Statistical significance was
defined as P < .05.
Estimation of factors associated with changes in pre-
scribing rates was addressed by a multivariable analysis of
antibiotic prescription counts using a random-effects nega-
tive binomial regression. The initial model specified the
number of antibiotic prescriptions as the outcome, a fixed
effect for study arm, two fixed effects for study period, with
baseline period as the reference, two arm × period interac-
tion effects, a random effect to account for repeated mea-
sures of NH rates, and an offset variable equal to the
natural log of estimated resident days/1000 days to account
for differences in exposure across NHs and periods. Empiri-
cal sandwich SEs were used to provide robustness against
possible misspecification of the model covariance structure
(ie, random intercepts model). Relative reductions in pre-
scribing rates in years 1 and 2 vs baseline were summarized
with incident rate ratios (IRRs) and their 95% confidence
intervals (CIs) for each arm. As arm × period interactions
were not significantly different from zero, they were
dropped, and a final main effects model was fitted to esti-
mate IRRs and their 95% CIs. All baseline characteristics
Table 1. Components of the Antibiotic Stewardship Training and Quality Improvement Intervention
Intervention Description/Example
Standardized system for recording antibiotic
prescribing
Monthly reporting of each antibiotic start, including drug, dose, duration, and
indication.
10-Module, 2-h prerecorded video training for
nursing staff
Available free at https://nursinghomeinfections.unc.edu/nurses.
Two 1-h training CDs distributed to all medical
providers
Included case examples of common issues in antibiotic stewardship in NHs.
These are downloadable as audiocasts from https://nursinghomeinfections.unc.
edu/medical-providers/.
Informative posters for nursing staff, changed
on a quarterly basis
Poster topics included antibiotic stewardship, urinary tract infections, respiratory
tract infections, and skin and soft tissue infections. See Supplementary
Appendix S1.
Pocket information and reminder cards for
nursing staff
Included SBARs for common situations,a common reasons for antibiotic
overprescribing, and an algorithm regarding recommendations for when to
obtain urine cultures. See Supplementary Appendix S1.
Pocket information and reminder cards for
medical providers
Includes common reasons for antibiotic overprescribing, plus NH infection
control guidelines. See Supplementary Appendix S1.
Information brochure in lay language about
antibiotic stewardship for residents and families
Includes the reasons why antibiotics are sometimes not needed and the need
for antibiotic stewardship. See Supplementary Appendix S1.
Quarterly quality improvement 1-page
newsletters to medical providers and nursing
directors and a baseline and 1-year quality
improvement poster for nursing staff
Included prescribing data individually for each participating NH (with deidentified
comparison data from other participating facilities). For an example, see
Supplementary Appendix S1.
Note: Implementation differed between study arms as follows: (a) planning in the NH chain arm was conducted in collaboration with the corporate lead
nurse, whereas in the medical provider arm, it was conducted in collaboration with the practice medical director; (b) the NH chain arm implemented a stan-
dardized system for recording antibiotic prescribing, whereas the medical provider arm used the systems that were already in place in the various homes; (c)
the nursing training used standardized videos in both arms, but in the NH chain arm, a supervisory nurse presided over the training, whereas in the medical
provider group, the medical director or a designated nurse practitioner or physician assistant presided over the training; and (d) in the medical arm, initial
training was conducted in a group setting, whereas in the NH chain arm, medical directors received a training CD.
Abbreviations: NH, nursing home; SBAR, situation, background, assessment, recommendation.
aThe SBAR is a framework commonly used in nursing to evaluate problems in clinical settings.
(Table 2) that differed between the study arms at P ≤ .15
were included in multivariable models (excluding variables
with empty cells).
Implementation costs were determined at the NH level
under the presumption that, as in this and any broad dissemina-
tion project, costs of intervention development would not be
borne by the individual NH. Labor costs associated with staff
training were estimated using data on involvement and time
spent by staff type, number of training sessions attended, and
reported time for record review; and results for individual
NHs were aggregated by study arm. Minutes spent were mul-
tiplied by the statewide average wage, using the 25th percen-
tile of the 2016 North Carolina Annual Wage/Salary Survey
for healthcare professionals (2015 data) as the average
wage.25 Nonlabor costs per NH were calculated by dividing
the cost of reproducing training materials by the number of
participating NHs.
RESULTS
Participating NHs were largely for profit, had a mean bed
size of 102, had 16% of beds licensed for short-term reha-
bilitation, and had an average overall rating of 2.8 on the
CMS Nursing Home Compare website (Table 2).26 None of
the NH characteristics differed significantly from all NHs in
North Carolina or between the two study arms, except that
the medical provider group’s NHs included five homes that
were not for profit and four that had dementia units,
whereas the NH chain was for profit and had no dementia
units. Age, sex, racial background, and insurance status of
the residents did not differ significantly between the arms;
however, provider group medical directors served as pri-
mary physician to a larger proportion of their NH residents
(93% vs 69%; P = .03).
During the 2-year intervention and follow-up period, staff
turnover tended to be higher in the NH chain arm. The mean
turnover rates for the administrator, director of nursing, and
infection preventionist over 2 years for the NH chain arm
were 0.6, 1.5, and 2.2 position changes, respectively; the
corresponding figures for the provider arm were 0.3, 0.8, and
1.0 (P = .18, P = .17, and P = .03, respectively). Medical direc-
tor turnover was also greater in the NH chain arm (0.4 vs
0.0; P = .02).
Comparison of the facility-level antibiotic prescribing rates
at baseline, year 1, and year 2 demonstrated marked variation
within study NHs from one year to the next, even within the
same NH (Figure 1). In two-group comparisons, however,
none of the primary or secondary outcomes significantly








P value for difference
between study armsa
NH Characteristics
For-profit ownership 22 (81) 14 (100) 8 (62) .02
Time in operation under current owner/corporation, y 13.3 (8.5) 11.8 (6.7) 14.9 (10.1) .34
Total No. of licensed NH beds 102 (41.3) 97 (39.7) 108 (43.9) .50
No. of licensed subacute or short-term beds 28 (16.1) 26 (15.4) 29 (17.3) .71
Dementia unit on site 4 (15) 0 (0) 4 (31) .04
Ventilator unit on site 1 (4) 0 (0) 1 (8) .48
Average overall rating on Nursing Home Compareb 2.8 (1.2) 2.7 (1.1) 2.8 (1.4) .92
Average quality rating on Nursing Home Compareb 3.2 (1.4) 3.4 (1.2) 3.0 (1.7) .53
Average time infection preventionist (nurse) devotes
to infection control, h/wk
8.2 (6.3) 8.3 (5.9) 8.1 (6.8) .93
NH Residents
Aged ≥85 y 40.6 (20.3) 37.7 (15.8) 43.7 (24.5) .45
Male sex 29.5 (12.3) 27.6 (8.8) 31.5 (15.4) .44
Race
Black or African American 32.1 (24.0) 34.6 (20.8) 29.3 (27.7) .56
White 66.9 (24.3) 64.6 (21.1) 69.5 (28.0) .61
Other 1.6 (5.2) 2.3 (7.2) 0.9 (1.6) .48
Dementia diagnosis 43.0 (19.9) 48.2 (15.7) 37.5 (22.9) .17
Primarily covered by Medicaid 53.7 (27.8) 54.6 (24.6) 52.7 (31.8) .85
Primarily covered by Medicare 20.9 (15.2) 23.6 (16.1) 17.6 (14.1) .29
Medical Providers
Residents with medical director as primary
physician, %
80.9 (29.5) 69.4 (35.9) 93.2 (13.3) .03
Length of time current medical director at NH, y 6.4 (6.2) 9.1 (6.6) 3.6 (4.3) .19
No. of medical providers in NH 5.1 (3.8) 5.5 (4.5) 4.7 (3.1) .59
Physicians 3.2 (3.4) 3.8 (3.6) 2.5 (3.0) .29
Nurse practitioners or physician assistants 1.9 (1.4) 1.6 (1.5) 2.2 (1.1) .27
Note: Data are given as number (percentage) or mean (SD).
Abbreviation: NH, nursing home.
aComputed using SAS 9.4 t-test or Fisher’s exact test.
bRatings are from 1 (poor) to 4 (excellent).
differed across study arms with respect to change in prescrib-
ing rates from baseline (Table 3).
Bivariate analyses found significant reductions in pre-
scribing across the majority of the outcomes, with reduc-
tions after 24 months generally being greater than those
after 12 months (Table 4). For the primary outcome, total sys-
temic antibiotic prescriptions per 1000 resident-days, NHs
experienced a 16% decrease at 12 months (P = .16) and a
20% decrease at 24 months (P = .004). This reduction largely
related to a significant difference in prescribing for presumed
Figure 1. Antibiotic prescribing rates by nursing home (NH) at baseline, 1 year, and 2 years after implementation of antibiotic
stewardship program. Each of the 27 NHs is represented by three vertical bars corresponding to the antibiotic prescribing rate per
1000 resident days during January to April of 2015, 2016, and 2017. ID indicates identification.
Table 3. Comparison of Temporal Changes between Intervention Arms in their Rates of Prescribing, Resistant
Infections, and Hospitalizations
Variablea

















Site-specific prescription rate/1000 resident-days
Total systemic
antibiotic prescriptions
11.92 12.91 -20.1 -11.8 .72 -11.6 -28.8 .06
UTI prescriptions 4.77 5.02 -17.4 -29.1 .52 -18.0 -39.4 .13
Respiratory tract
infection prescriptions
3.13 3.91 -18.9 -15.9 .94 -6.4 -27.7 .24
Skin infection
prescriptions
1.59 1.63 5.7 3.1 .98 -5.5 -13.0 1.00
Time between
prescriptions, d
94.85 85.43 29.4 19.1 .87 28.2 48.6 .28
Treated infections per 10 000 resident-days
Clostridium difficile 3.89 2.37 -23.1 36.7 .79 -38.9 -10.7 .82
MRSA 2.58 0.85 -11.6 68.2 .09 -23.2 89.6 .37
Hospitalization rate per 1000 resident-days
All hospitalizations 3.58 2.72 -15.4 -9.2 .84 1.9 -10.8 .30
Readmissions
within 30 d
1.93 1.09 -26.9 -31.2 .30 -12.3 -20.1 .73
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; NH, nursing home; UTI, urinary tract infection.
aWilcoxon rank-sum test comparing temporal changes in outcome rates between study arms; one chain NH had its data excluded for 1 month in year 1
(2017) as it did not report antibiotic prescriptions.
urinary tract infections (UTIs). Incidence of C. difficile and
MRSA infections, hospitalizations, and hospital readmissions
did not change significantly. Additionally, no cases were
reported of sepsis associated with a decision to not give an anti-
biotic based on program-associated training.
In the initial multivariable model for total systemic antibi-
otic prescriptions, the arm × period interactions were not sig-
nificant by a joint 2 df Wald test (P = .202). As there was
insufficient evidence for the existence of such differences, the
interactions were removed and a main effects multivariable
model was fitted to estimate temporal changes assumed to be
common across arms. This final model also found that
both the 12-month (P = .029) and 24-month (P = .001) period
effects were statistically significant, indicating an overall reduc-
tion in total systemic antibiotic prescribing. Specifically, relative
to the baseline rate, the adjusted rate of antibiotic prescribing
was an estimated 18% lower in months 9 to 12 of the interven-
tion period (IRR = 0.82; 95% CI = 0.69-0.98) and 23% lower
in months 19 to 24 (IRR = 0.77; 95% CI = 0.65-0.90). One
baseline characteristic remained in the model—percentage of
residents with the medical director as primary physician, with a
10% increase in residents with the medical director as primary
physician associated with a 4.1% reduction in antibiotic pre-
scribing (IRR = 0.96; 95%CI = 0.92-0.99).
Staff turnover and antibiotic prescribing were not signifi-
cantly associated in the total sample, but for the NH chain arm,
there was a significant negative correlation between nurse turn-
over and prescribing changes during year 1 (ρ = -0.58; P = .03)
and between medical director turnover and year 2 change
(ρ = -0.68; P = .007). When included in multivariable models,
however, neither staff turnover variable was significant.
During the intervention, the mean rate of urine culture
ordering across the 27 NHs reduced from 4.15 cultures per
1000 resident-days at baseline to 3.11 per 1000 resident-
days during intervention months 21 to 24 (P = .03).
We estimated 2-year implementation costs for on-site
staff training to range from a low of $151 (medical provider
group NH, where no training was documented) to a high of
$3459 (chain NH, where all staff attended in-service train-
ing). Chain NHs had an average cost of $1270 for the live
training, and medical provider homes had an average cost of
$383, due to differential participation in formal training ses-
sions. In addition, two chain homes and four medical pro-
vider homes had zero costs, due to no documentation that
training occurred. This difference between the study arms
was significant (two-tailed t-test with unequal variances;
P = .01). An additional cost was $194 per NH for the training
materials (brochures, posters, audiocasts) provided by the
research team. Based on these estimates, if the program was
broadly implemented in a similar manner, the total training
and material costs per NH would range from $354 to $3653,
depending on labor force participation in the training. Medical
provider time (eg, listening/reading training materials, meeting
with nursing staff, and reviewing reports) would be additional.
DISCUSSION
This 2-year implementation trial in 27 NHs demonstrated
that, even in highly varied, community NHs, significant
reductions in antibiotic prescribing can be achieved by a
low-cost, standardized antibiotic stewardship program. Fur-
thermore, it demonstrated that an antibiotic stewardship
Table 4. The 1- and 2-Year Changes in Rates of Prescribing, Resistant Infections, and Hospitalizations among all 27
Community Nursing Homes Participating in the Antibiotic Stewardship Intervention
Variable Baseline




















12.40 10.42 1.98 (4.87) -16.0 .16 9.89 2.50 (4.13) -20.2 .004




3.51 2.91 0.59 (1.71) -17.1 .11 2.88 0.62 (1.78) -18.0 .15
Skin infection
prescriptions
1.61 1.67 -0.06 (1.04) 3.7 .54 1.46 0.15 (0.89) -9.3 .22
Time between
prescriptions, d
90.32 112.61 -22.29 (53.76) 24.7 .22 124.20 -33.89 (55.84) 37.5 .004
Treated infections per 10 000 resident-days
Clostridium difficile 3.16 3.11 0.05 (4.59) -1.6 .44 2.25 0.91 (4.61) -28.8 .49
MRSA 1.75 1.87 -0.12 (2.35) 6.9 .91 1.80 -0.05 (3.10) 2.9 .87
Hospitalization rate per 1000 resident-days
All hospitalizations 3.16 2.75 0.42 (1.61) -13.0 .27 3.05 0.11 (1.43) -3.5 .98
Readmissions
within 30 d
1.59 1.20 0.38 (0.91) -24.5 .10 1.29 0.34 (1.15) -18.9 .39
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; UTI, urinary tract infection.
aWilcoxon signed-rank test comparing temporal change relative to baseline rates without distinction by study arm; one chain nursing home had its data
excluded for 1 month in year 1 (2017) as it did not report antibiotic prescriptions for that month.
program can be successful when primary responsibility for
dissemination is through either a NH chain or a medical
provider group. However, as exemplified by our results
showing greater improvement in the physician arm in year
2, and the association we noted between the proportion of
residents cared for by the medical director, engaging physi-
cians and other medical providers is likely to be especially
critical in achieving long-term success. This is because NH
staff turnover rates are high, thereby creating a need for
intensive and ongoing reeducation to maintain knowledge
of and enthusiasm for antibiotic stewardship efforts.
There are many reasons for antibiotic overprescribing in
NHs. They house complex, frail residents, in whom infections
can evolve rapidly and present atypically.27,28 Providers are
rarely on site; so, a substantial proportion of treatment deci-
sions are made without a physician, nurse practitioner, or phy-
sician assistant examining the patient.29,30 Adding to the
challenge of obtaining an adequate assessment is the fact that
the majority of NH residents have cognitive impairment31 and
that on-site laboratory testing is rarely available.32 In such
decision-making situations, medical providers tend to over-
value antibiotics and underestimate their adverse effects.29
Additionally, opinions are prevalent among many nurses and
providers that are unsupported by the scientific literature but
lead to antibiotic overuse; examples include belief that changes
in urine color or odormerit antibiotic treatment,33 that asymp-
tomatic bacteriuria should be treated,34 and that nonspecific
status changes, such as weakness or decreased oral intake,
should be considered a UTI until proved otherwise.29,35
To address these issues, several expert panels have
developed consensus standards for diagnosis of UTI,36,37
and to identify when antibiotic use is appropriate.38,39 Most
notable are the criteria of Loeb et al,38 which are for antibi-
otic initiation, and the criteria of McGeer,39 which were
designed for retrospective surveillance. Unfortunately, both
have substantial limitations in the clinically challenging NH
setting. Loeb himself was unable to reduce antibiotic pre-
scribing using his criteria40; other multisite studies have also
had difficulty reducing prescribing using similar methods41;
and our earlier trial, while lowering prescribing rates, found
no correlation between Loeb criteria adherence and changes
in prescribing.42 Because of these issues, our education
focused on when not to give antibiotics rather than when to
give them,23 a strategy that had been successfully
implemented in our group’s prior efficacy study.22 We attri-
bute the success of our trial to this approach, and to provi-
sion of a range of education and quality improvement
modalities across an extended period of time to all parties
involved in decision making.
Although our intervention was standardized across both
study arms and all NHs, implementation and results were
highly variable (Figure 1). Within individual NHs, interest in
and adherence to the project would often change markedly
after turnover of a key position, such as the infection pre-
ventionist, medical director, or administrator. This reflects
the reality of community NHs, in that far fewer professionals
are present and their time is stretched much thinner than in
hospital settings. For example, infection preventionist nurses
in study NHs invariably had other roles and typically
devoted only 5 to 10 hours a week to all infection-related
responsibilities. This allocation contrasts with hospital set-
tings, where infection control is typically its own department,
employing a physician or epidemiologist, one or more
full-time nurses, surveillance personnel, secretarial staff, and
computer support personnel.43 Another source of variation
in intervention response was uneven interest and enthusiasm
on the part of the designated leaders in both arms, as
evidenced by the wide variation in the proportion of nursing
staff formally trained, based on training logs used to register
continuing education credit. Despite these issues, we were
able to achieve overall reductions in antibiotic prescribing.
The study has several potential limitations. Because
there was insufficient evidence to detect significant differ-
ences in antibiotic prescribing changes between the study
arms, the main effects model was fitted to estimate temporal
reductions in antibiotic prescribing common across study
arms. It is possible that a larger study could have identified
a difference between the arms. Additionally, concurrent to
this study, national attention to antibiotic prescribing in
NHs was building, which could have contributed in part to
the program’s success. In addition, the study attempted to
gather implementation data from nursing staff and medical
providers, but high turnover and nonresponse rates severely
limited our capacity to understand the mechanisms by
which some NHs were more successful than others.
One goal of antibiotic stewardship is reduction in antibiotic
resistance rates and invasive infections with pathogens, such
as C. difficile, or MDROs, such as MRSA and carbapenem-
resistant Enterobacteriaceae. Here, our study was unable to
demonstrate change (Tables 2 and 3). Such a result was not
unexpected, however, as such reductions may take years to take
effect in the best of circumstances44 and reductions inC. difficile
rates are in large measure tied to hospital antibiotic use.45 Fur-
thermore, antibiotic stewardship is but one tool in infection pre-
vention and control; effective programs must also include hand
hygiene, contact precautions, decolonization measures, and
environmental decontamination.46 All of these underscore the
need for greater effort to improve infection management and
antibiotic stewardship, as has now been mandated by the CMS
and for which implementation is only beginning.
CONCLUSIONS
Antibiotic stewardship programs can be successfully dissemi-
nated in community NHs through either NH administration
or medical provider groups. Medical director involvement is
an important element of program success.
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